National Advisory Committee on Sexually Transmitted and Blood-Borne Infections (NAC-STBBI): Workplan
On this page
Preamble
The National Advisory Committee on Sexually Transmitted and Blood-Borne Infections (NAC-STBBI) provides the Public Health Agency of Canada (PHAC) with ongoing and timely advice for the development of public health guidance related to STBBI management, in support of PHAC's mandate to prevent and control infectious diseases in Canada.
Recommendations developed in collaboration with the NAC-STBBI inform PHAC's STBBI Guides for Health Professionals (the Guides). The Guides outline national recommendations for the screening and diagnosis of STBBI, and the treatment of sexually transmitted infections (STI) of national public health importance.
The following workplan represents priority selections to be undertaken by the NAC-STBBI. It is acknowledged that not all of these topics will be addressed over the next three years (2024-2027). Topics that are not addressed will be carried forward to subsequent years.
The following triggers may drive the addition of items to the NAC-STBBI workplan:
- Internal inconsistency
- Public health emergency
- New safety signal detected
- Changes in disease epidemiology
- Publication of key trials or evidence
- New treatment options or screening technologies
- Changes in antimicrobial resistance (AMR) patterns
- Recommendation adopted by other reputable organizations
- New Canadian recommendations from PTs and public health organizations
2024-2027 workplan
| Initiative/Topic | Policy/Program issue | Trigger(s) |
|---|---|---|
| Work currently underway | ||
| Doxycycline prophylaxis | Effectiveness of doxycycline prophylaxis for the prevention of bacterial STI. | New prevention option for bacterial STI. |
| Impact of widespread doxycycline prophylaxis use on AMR patterns and trends. | Increasing usage of doxycycline prophylaxis. | |
| Gonorrhea | Effective dose for successfully treating uncomplicated gonorrhea at all anatomical sites with ceftriaxone. | Changes in global AMR patterns and changes in treatment recommendations from other international organizations. |
| Effective treatment options for gonorrhea, including monotherapy and combination therapy. | Rising rates of gonorrhea in Canada and changes to AMR patterns. | |
| Gonorrhea and chlamydia | Effective screening approaches (including the frequency and intervals to screen) for sexually active adults and adolescents. | Release of recommendation by the Canadian Task Force on Preventive Health Care. |
| Next projects | ||
| Chlamydia | Review and update of treatment recommendations to improve patient outcomes. | Increasing risk of macrolide resistance. |
| Human immunodeficiency virus | Review and update of the HIV Screening and Testing Guide. | Increased usage of PrEP and PEP, novel testing modalities, changes to laboratory algorithms and range of prevention strategies. |
| Mycoplasma genitalium | Update treatment recommendations to improve patient outcomes. | Increasing AMR to azithromycin and moxifloxacin. |
| Syphilis | Prenatal screening recommendation to prevent congenital syphilis. | Rising rates of infectious and congenital syphilis nationally and internationally. |
| Review and update of preferred and alternative treatment options to improve patient outcomes. | Rising rates of syphilis | |
Page details
- Date modified: